Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SKP2 | Q13309 | 1/20 | 0.40 |
| ▸ | IGF1R | P08069 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.36 |
| ▸ | CDK1 | P06493 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.35 |
| ▸ | CYP4F11 | Q9HBI6 | 1/20 | 0.35 |
| ▸ | CYP4F12 | Q9HCS2 | 1/20 | 0.35 |
| ▸ | CBS | P35520 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1611860 | 1.00 | SKP2 (0.40) | SKP2IGF1RALOX15CDK1CYP3A4 | |
| SCHEMBL1611829 | 0.98 | SKP2 (0.41) | SKP2IGF1RALOX15CDK1CYP3A4 | |
| SCHEMBL1610850 | 0.93 | SKP2 (0.42) | SKP2IGF1RALOX15CYP3A4CYP2D6 | |
| SCHEMBL1611294 | 0.85 | SKP2 (0.36) | SKP2CYP3A4CYP2D6CYP2C9CYP1A2 | |
| SCHEMBL31556195 | 0.84 | SKP2 (0.50) | SKP2IGF1RALOX15CDK1CYP3A4 | |
| SCHEMBL8827605 | 0.82 | CDK1 (0.42) | SKP2IGF1RALOX15CDK1CYP3A4 | |
| SCHEMBL1610221 | 0.81 | CBS (0.39) | SKP2CYP3A4CYP2D6CYP2C9CYP1A2 | |
| SCHEMBL1611063 | 0.81 | CBS (0.39) | SKP2CYP3A4CYP2D6CYP2C9CYP1A2 | |
| SCHEMBL8766878 | 0.80 | SKP2 (0.41) | SKP2IGF1RALOX15CYP3A4CYP2D6 | |
| SCHEMBL1611200 | 0.79 | CBS (0.36) | SKP2CYP3A4CYP2D6CYP2C9CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2011-04-14 | — | — | US | disclosed |
| EP-2248818-A1 | ORGANIC SEMICONDUCTOR MATERIAL | Sumitomo Chemical Company, Limited (JP) | 2010-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | OR10J3, TST, OR51E2 | SKP2 273/4885IGF1R 684/4885ALOX15 1511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.